Search
Kalvista Pharmaceuticals Inc
KALVAdd to Watchlist
26.990USD
0.0000.00%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.44BMarket Cap
LossP/E TTM
Kalvista Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-10The current valuation score of Kalvista Pharmaceuticals Inc is 8.97, ranking 56 out of 390 in the Biotechnology & Medical Research industry. Its current P/E ratio is -62.75, which is -97.85% below the recent high of -1.35 and 0.00% above the recent low of -62.75.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
